| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/2000 | CA2355096A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists |
| 07/06/2000 | CA2354431A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2354053A1 A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2353961A1 Heteroaromatic derivatives having an inhibitory activity against hiv integrase |
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2352423A1 Treatment of retroviral infections with oxyphenbutazone |
| 07/06/2000 | CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | CA2349557A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2348740A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2347671A1 Succinoylamino benzodiazepines as inhibitors of a.beta. protein production |
| 07/06/2000 | CA2321864A1 Interleukin-6 production inhibitor |
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/06/2000 | CA2320730A1 Thrombin or factor xa inhibitors |
| 07/05/2000 | EP1016715A1 Oligonucleotides having a conserved G4 core sequence |
| 07/05/2000 | EP1016669A1 New derivatives of erythromycin, process for making them as well as their use as medicaments |
| 07/05/2000 | EP1016665A1 Process for the selective preparation of z-isomers of 3-(2-substituted vinyl)cephalosporins |
| 07/05/2000 | EP1016664A1 Fused thiophene compounds and medicinal use thereof |
| 07/05/2000 | EP1016646A1 Intermediates for the preparation of cephalosporines containing on the 7-position a substituted benzyloximino radical |
| 07/05/2000 | EP1016411A1 Sulodexide for restenosis therapy |
| 07/05/2000 | EP1016410A1 Glycosaminoglycans for the treatment for pre-eclampsia and related diseases |
| 07/05/2000 | EP1016408A1 C-c chemokine production inhibitor |
| 07/05/2000 | EP1016407A1 Remedial agent for neural degeneration |
| 07/05/2000 | EP1016406A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption |
| 07/05/2000 | EP1016405A2 Arylating medicaments |
| 07/05/2000 | EP1016404A1 Aqueous preparation of beta-carotene |
| 07/05/2000 | EP1015884A1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 07/05/2000 | EP1015630A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/05/2000 | EP1015627A1 Method for detecting a target compound using a nucleic acid ligand |
| 07/05/2000 | EP1015600A1 Statin production by fermentation |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015492A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/05/2000 | EP1015474A1 Don-1 gene and polypeptides and uses therefor |
| 07/05/2000 | EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R) |
| 07/05/2000 | EP1015472A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| 07/05/2000 | EP1015471A1 Hypoxia-regulated genes |
| 07/05/2000 | EP1015470A1 Composition and method for delivery of nucleic acids |
| 07/05/2000 | EP1015469A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/05/2000 | EP1015467A1 6,9-bridged erythromycin derivatives |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015459A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 07/05/2000 | EP1015458A1 Furopyrrolidine derivatives and their use as serine protease inhibitors |
| 07/05/2000 | EP1015457A1 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors |
| 07/05/2000 | EP1015456A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors |
| 07/05/2000 | EP1015455A1 Pyrrolopyrrolone derivatives |
| 07/05/2000 | EP1015454A1 Method of inhibiting serine protease enzymes |
| 07/05/2000 | EP1015453A1 3-(iodophenoxymethyl) carbapenem antibacterials |
| 07/05/2000 | EP1015452A1 Optionally protected 3-hydroxymethyl carbapenems and synthesis |
| 07/05/2000 | EP1015451A1 Tetrahydro gamma-carbolines |
| 07/05/2000 | EP1015450A1 Novel pyridazine compounds |
| 07/05/2000 | EP1015449A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors |
| 07/05/2000 | EP1015448A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods |
| 07/05/2000 | EP1015447A1 Piperidinylmethyloxazolidinone derivative |
| 07/05/2000 | EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 07/05/2000 | EP1015445A1 Antimicrobial quinolones, their compositions and uses |
| 07/05/2000 | EP1015444A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 07/05/2000 | EP1015443A1 Thromboxane ligands |
| 07/05/2000 | EP1015441A1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 07/05/2000 | EP1015439A1 Prenyl transferase inhibitors |
| 07/05/2000 | EP1015438A1 Protease inhibitors |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 07/05/2000 | EP1015429A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 07/05/2000 | EP1015427A1 Substituted 2-pyrrolidinone activators of pkc |
| 07/05/2000 | EP1015423A1 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs |
| 07/05/2000 | EP1015422A1 Hiv matrix protein tyrosine position 29 pocket binders |
| 07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 07/05/2000 | EP1015417A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| 07/05/2000 | EP1015416A2 Method for the preparation of citalopram |
| 07/05/2000 | EP1015413A1 Anti-cancer compounds |
| 07/05/2000 | EP1015106A1 Betaine product, method for its manufacture, and its use |
| 07/05/2000 | EP1015033A2 Substituted perylenequinones for use in photodynamic therapy |
| 07/05/2000 | EP1015030A2 Photochemotherapeutic compositions |
| 07/05/2000 | EP1015027A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 07/05/2000 | EP1015026A2 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 07/05/2000 | EP1015022A1 New improved formulation for treatment of thromboembolism |
| 07/05/2000 | EP1015019A1 Compositions and methods of therapy for igf-i-responsive conditions |
| 07/05/2000 | EP1015011A1 Peptide nucleic acids having antibacterial activity |
| 07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1015000A1 Antiviral polymers comprising acid functional and hydrophobic groups |
| 07/05/2000 | EP1014999A1 Cationic polymers as toxin-binding agents |
| 07/05/2000 | EP1014998A1 Polymeric compositions |
| 07/05/2000 | EP1014997A1 Substance and method for reduction of lipids and cholesterol |
| 07/05/2000 | EP1014996A1 Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses |
| 07/05/2000 | EP1014995A1 Compositions and methods for preventing restenosis following revascularization procedures |
| 07/05/2000 | EP1014994A1 Phosphono-carboxylate compounds for treating amyloidosis |
| 07/05/2000 | EP1014993A1 New use for budesonide and formoterol |
| 07/05/2000 | EP1014992A1 Use of delta 5-androstenes in the treatment of hiv wasting syndrome |
| 07/05/2000 | EP1014991A1 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
| 07/05/2000 | EP1014990A1 Method of treating a tumor |
| 07/05/2000 | EP1014989A1 Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 07/05/2000 | EP1014988A2 Treatment of hepatic cirrhosis |
| 07/05/2000 | EP1014987A1 Oral compositions of levosimendan |
| 07/05/2000 | EP1014986A1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT 1 BETA ANTAGONIST OR PARTIAL AGONIST |
| 07/05/2000 | EP1014985A1 A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT 1B ANTAGONIST OR PARTIAL AGONIST |
| 07/05/2000 | EP1014984A1 Inhibitors of prenyl-protein transferase |